Celldex and Seattle Genetics Updates
This company is best known for its immunotherapy technology. Its clinical candidates include vaccines designed to train the “generals” of the immune system, antigen-presenting dendritic cells. The company calls this platform APC Targeting Technology, and its leading candidate in this area has already completed Phase 1 trials.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Technology Profits Confidential
With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.